AKAN: Akanda Corp. Stock

SIC 2833 – Medicinal Chemicals and Botanical Products

Valuation
Market Cap ($M) 2.38
Enterprise Value ($M) 2.38
Book Value ($M) 0.00
Book Value / Share 0.00
Price / Book n/a
NCAV ($M) 0.00
NCAV / Share 0.00
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) n/a
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio n/a
Current Ratio n/a

Balance Sheet (mrq) ($M)
Current Assets 0.00
Assets 0.00
Liabilities 0.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
2024-02-20 13G/A Halo Collective Inc. 0.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-07 1,190 11,551 10.30
2025-03-06 4,824 19,993 24.13
2025-03-05 21,754 52,238 41.64
2025-03-04 2,319 12,241 18.94

(click for more detail)

Similar Companies
ADVM – Adverum Biotechnologies, Inc. AGEN – Agenus Inc.
AIMD – Ainos, Inc. AKBA – Akebia Therapeutics, Inc.
ALBT – Avalon GloboCare Corp.


Financial data and stock pages provided by
Fintel.io